Search results
Results from the WOW.Com Content Network
Ezetimibe, sold under the brand name Zetia among others, is a medication used to treat high blood cholesterol and certain other lipid abnormalities. [3] [4] Generally it is used together with dietary changes and a statin. [5]
Lercanidipine is used in form of the hydrochloride, [4] which is a slightly yellow crystalline powder and melts at 197 to 201 °C (387 to 394 °F) in crystal form I or 207 to 211 °C (405 to 412 °F) in crystal form II. [10] It is readily soluble in chloroform and methanol, but practically insoluble in water. [11]
The Port of Zeebrugge (also referred to as the Port of Bruges or Bruges Seaport) is a large container, bulk cargo, new vehicles and passenger ferry terminal port on the North Sea. The port is located in the municipality of Bruges , West Flanders in the Flemish Region of Belgium , handling over 50 million tonnes of cargo annually.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
Dienogest 2 to 3 mg and estradiol valerate 1 to 3 mg oral tablets (Qlaira) (not available in U.S.) – indicated for contraception [32] Each dark yellow active tablet contains 3 mg estradiol valerate; Each medium red active tablet contains 2 mg estradiol valerate and 2 mg dienogest; Each light yellow active tablet contains 2 mg estradiol ...
Dexamyl (or Drinamyl in the UK) was the brand name of a combination drug composed of amobarbital (previously called amylbarbitone) and dextroamphetamine (Dexedrine) within the same pill.
[1] 273 mg of sodium is contained in the tablets sold in Australia and New Zealand. [ 2 ] Berocca causes urine to turn deep yellow in colour [ citation needed ] – this is due to the excess vitamin B 2 [ citation needed ] (also known as Riboflavin, with "flavus" meaning "yellow" in Latin) being passed via urine.
Lemborexant is used in the treatment of insomnia in adults. [3]A major systematic review and network meta-analysis of medications for the treatment of insomnia published in 2022 found that lemborexant had an effect size (standardized mean difference (SMD)) against placebo for treatment of insomnia at 4 weeks of 0.36 (95% CI Tooltip confidence interval 0.08 to 0.63) and at 3 months of 0.41 (95% ...